

| Revenue | $10 - $100 million See Exact Annual Revenue |
|---|---|
| Employees | 100 - 500Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Address | 1249 South River Road Suite 17 Cranbury, NJ 08512 |
| Iveric Bio | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $10 - $100 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Iveric Bio P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| IVERIC BIO Pharmaceutical preparations in the nature of ophthalmic preparations; pharmaceutical preparations for treatment of ocular, macular and other retinal diseases and conditions; Pharmaceutical preparations for use in the human eye for treatment of ocular, macular and other retinal diseases and conditions | 04/15/2019 |
| OPHINIDI Pharmaceutical preparations for use in the field of ophthalmology; pharmaceutical preparations for treating degenerative eye diseases; pharmaceutical preparations for treating Age-Related Macular Degeneration; pharmaceutical preparations for the treatment of eye, ocular, macular and other retinal diseases and conditions; pharmaceutical preparations for the treatment of eye diseases and conditions | 09/07/2016 |
| OCLODIF Pharmaceutical preparations for use in the field of ophthalmology; pharmaceutical preparations for treating degenerative eye diseases; pharmaceutical preparations for treating Age-Related Macular Degeneration; pharmaceutical preparations for the treatment of eye, ocular, macular and other retinal diseases and conditions; pharmaceutical preparations for the treatment of eye diseases and conditions | 09/07/2016 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| WCG CLINICAL | Princeton, NJ | 100 |
| CERTARA USA | Princeton, NJ | 33 |
| TAIHO ONCOLOGY | Princeton, NJ | 21 |
| IVERIC BIO | Cranbury, NJ | 19 |
| THERADEX SYSTEMS | Princeton, NJ | 8 |
| HOVIONE | East Windsor, NJ | 7 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |